Lanzhou medical quality management assessment evaluation rules

Lanzhou medical quality management assessment evaluation rules Supervision is an important means for the normal operation of society. In order to establish a long-term mechanism for the quality supervision of medical institutions, the Lanzhou City Health Bureau recently issued the "Management and Evaluation of Medical Quality Management (Trial)" and it will be formally implemented on October 22. This also marks a clear basis for future quality supervision of public hospitals in Lanzhou. The "Detailed Rules" covers nine aspects and 214 specific assessment indicators. The demerit points will be applied to the items that fail to meet the standards or have problems. The assessment scores will be linked to the hospital's performance evaluation.

Nine measures to improve the quality of medical <br> <br> the "rules" are Municipal Health Bureau in conjunction with reform of public hospitals, "Medical Quality Miles" special rectification of antibiotics and other regulatory measures, the introduction of two or more hospitals in Lanzhou specific Evaluation and evaluation basis. Covers nine areas:

First, the implementation of various medical systems, the implementation of clinical path management, to ensure the quality of medical care and medical service security and effectiveness;

Second, strengthen the management of medical institutions, strengthen service awareness, optimize service processes, improve the level of medical services, and improve the people's experience in seeing a doctor;

Third, implement the goal of patient safety, implement public hospital affairs, and standardize the construction of related departments in medical institutions;

Fourth, strengthen the clinical application and management of medical technology;

Fifth, strengthen the management of medical affairs in medical institutions and promote the rational use of drugs in clinical practice;

Sixth, strengthen nursing work, implement basic nursing, improve nursing services, and improve nursing quality;

Seventh, conscientiously implement the “Measures for Hospital Infection Management” to prevent and control hospital infections in key hospital departments and key links;

Eighth, to strengthen laboratory biosafety and quality control;

Ninth, strengthen the implementation of the responsibility system for safety production and ensure medical safety.

Service process time-out will be penalized <br> <br> the "rules" including a total of 214 specific assessment rules, most of which involved health care services assessment project. There were no attending records of the attending physicians within 48 hours of admission; the attending physician had less than 2 rounds of weekly visits, the chief physician had fewer than 1 round of weekly visits, and whether the positive and negative deans were inspected every week.

The assessment rules also impose restrictions on the hospital service process time. The waiting time for registering, marking, charging, taking drugs and other service windows exceeds 10 minutes; the time for ultrasonic examination from the beginning of the inspection to the issuing of the results exceeds 30 minutes; the time for the inspection of large-scale equipment inspection projects from the application form of the inspection report to the issuance of inspection results exceeds 48 hours; Blood, urine, stool routine examination, electrocardiogram, and routine image inspection items have taken more than 30 minutes from the start of the examination to the issue of results; biochemical, coagulation, and immunological tests have passed test results from the start of the examination to more than 6 hours; bacteriology and other test items have been The time from the beginning of the examination to the result of the examination was more than 4 days; the pathological section of the frozen section of the operation was scored more than 30 minutes after the examination was submitted and the result was issued.

If the care is not received, the complaint will be deducted by 5 points. The "Detailed Rules" requires that the nursing department should rationally allocate and deploy clinical nurses in the hospital in accordance with clinical nursing workload. Responsible nurses should be responsible for the patient's condition, focus of observation, treatment points, diet and nutritional status, physical self-care ability, etc., and be able to cooperate with the competent physician. In contrast to the medical records, if the ward responsible nurse is spot-checked for the situation of the responsible patient, he will be deducted by 2 points if he or she is not mastered or unclear. The ratio of nurses to actual beds in hospital wards was less than 0.4:1. The actual ratio of ICUs to nurses in the wards did not reach 1:2.5-3, with 4 points deducted. In addition, the hospital should conduct patient satisfaction surveys on a regular basis and investigate complaints of patients. If the patient is found to have complaints and opinions during the random inspection, he will be deducted 5 points.

A point-check will also be scored if the unpaid nurse's salary distribution is reasonable and equal pay for equal work is achieved.

Orlistat

Orlistat is a long-acting and potent specific gastrointestinal lipase inhibitor. It is white or off-white powder at room temperature. It is insoluble in water, soluble in chloroform, and easily soluble in ethanol. It passes through the stomach and small intestine cavity. Intragastric lipase and pancreatic lipase active codon form a covalent bond to inactivate the enzyme. Fat in food cannot be broken down into free fatty acids and monoacylglycerols, so the fat cannot be absorbed and utilized, thereby reducing the body's caloric intake and controlling body weight. This medicine does not need to be absorbed through the body to exert its effects. At the usual dose, fat absorption can be suppressed by 30%. It is rarely absorbed after oral administration and can be metabolized and inactivated in the intestine. The metabolic site is on the wall of the gastrointestinal tract, and the elimination half-life is about 14 to 19 hours. About 97% of this product is excreted with feces, of which 83% is excreted in the original form.

Orlistat can be used clinically for obesity and hyperlipidemia. Under normal circumstances, 120mg can be taken orally once a day, three times a day, and taken within one hour after a meal. After taking the medicine for 2 weeks, the weight may start to decrease. It can be taken continuously for 6 to 12 months. If the dose is increased to more than 400 mg per day, its effect will no longer be enhanced.

Orlistat Dosage,Orlistat Weight Loss,Orlistat Function,Orlistat For Weight Loss

Jinan Prosperity International Trade Co. Ltd , https://www.cnsrtrade.com